Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Karlheinz Nocker"'
Autor:
Karoline Droebner, Emanuel Haasbach, Sabine E. Dudek, Gerhard Scheuch, Karlheinz Nocker, Sebastian Canisius, Christina Ehrhardt, Georges von Degenfeld, Stephan Ludwig, Oliver Planz
Publikováno v:
Frontiers in Microbiology, Vol 8 (2017)
Influenza is a respiratory disease that causes annual epidemics. Antiviral treatment options targeting the virus exist, but their efficiency is limited and influenza virus strains easily develop resistance. Thus, new treatment strategies are urgently
Externí odkaz:
https://doaj.org/article/45e0678d2d96403fb20ea4c488bbe892
Autor:
Tobias Welte, Gerhard Scheuch, Rolf Naumann, Karlheinz Nocker, Oliver Planz, Stephan Pleschka, Thomas Hofmann, Stephan Ludwig, Sebastian Canisius
Publikováno v:
Emerging Microbes & Infections
Influenza has been a long-running health problem and novel antiviral drugs are urgently needed. In pre-clinical studies, we demonstrated broad antiviral activity of D, L-lysine-acetylsalicylate glycine (LASAG) against influenza virus (IV) in cell cul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82c6bd56c5d7f5be7c489c34df08ca7d
https://doi.org/10.1038/s41426-018-0023-3
https://doi.org/10.1038/s41426-018-0023-3
Autor:
Bernhard Muellinger, Klaus F. Rabe, Gerhard Scheuch, Karlheinz Nocker, Thomas Hofmann, Guenter Menz, Claus Vogelmeier, Sebastian Canisius, Peter Kardos
Publikováno v:
European Respiratory Journal. 45:1273-1282
This phase 2/3 randomised, parallel-group, placebo-controlled trial investigated oral corticosteroid (OCS)-sparing efficacy, safety and tolerability of nebulised budesonide (Bud) administered with a novel computer-controlled, compressor-driven inhala
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::680928e14cad07e0337db3cd2aeb53bb
https://doi.org/10.1183/09031936.00152014
https://doi.org/10.1183/09031936.00152014